Clinical Trial Update: Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia

View source ↗

Summary

A clinical trial update shows that a higher percentage of CD34+ CD38- cells in leukapheresis products, detected by multiparameter flow cytometry, predicts unsus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Myeloid Leukemia | Status: COMPLETED